Viral preparations and methods for treating and modulating mitochondrial effects of coronavirus infections
US12297460B1 · kind B1 · utility
Inventor
Key dates
| Filing date | Jul 7, 2021 |
| Grant date | May 13, 2025 |
| Priority date | — |
| Expiry date | Jul 7, 2041 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2770/20034
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Attenuate coronavirus species that are able to fully replicate and spread are proposed together with the methods of obtaining thereof. The proposed coronavirus species are intended to treat and prevent viral infections including all those caused by coronavirus species that affect humans as the COVID-19 caused by the SARS-CoV2. Compared with other treatment or vaccine alternatives, the availability of such attenuate coronavirus species does not require of significant distribution and production resources.Some of the embodiments of the invention involve the use of the attenuate coronavirus species in formulations or compositions that have to be approved as safe and effective for therapeutic use in specific territories by a valid regulatory agency as the Food and Drug Agency (FDA) in the United States.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.